For the digital health and pharma suppliers we cover, February was a month of changes, with CEOs coming and going (sometimes dramatically), and several other C-Suite and board shake-ups.
It’s honestly getting harder to separate AI-powered pharma companies from pharma-focused AI companies as AI becomes more and more embedded in biopharma operations.
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.